Polatuzumab (Anti-CD79b)

Polatuzumab (Anti-CD79b) is a monoclonal antibody which targets CD79b that is found on the surface of B cells. The antibody-drug conjugate (ADC) Polatuzumab vedotin, marketed under the brand name Polivy, is a medicine used to treat diffuse large B-cell lymphoma (DLBCL), a type of non-Hodgkin lymphoma. This ADC drug is a conjugate that combines a monoclonal antibody Polatuzumab, linker and a chemotherapy drug monomethyl auristatin E (MMAE). This biosimilar antibody is used for research only. MW: 145.5 KD.

Product Details
Species Reactivity	Human
Host/Isotype	Human IgG1
Class	Monoclonal
Type	Recombinant Antibody
Immunogen	Human CD79b
Clone	Polatuzumab biosimilar
Conjugate	Unconjugated
Purity	99%
Molecular Weight	145.5 KD
Protein Concentration	1mg/ml
Storage Condition	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Storage Buffer	100mM Pro-Ac, 20mM Arg-Ac, pH 5.0